Nature Reviews Cardiology
Volume 11, No 3 March 2014
ALSO THIS MONTH
FREE POSTER
Dyslipidaemia and its treatment
Robert A. Hegele & Philip Barter
Disorders of plasma lipid and lipoprotein metabolism can cause atherosclerotic cardiovascular disease. This poster displays the main lipid-metabolism pathways in the body, the points at which monogenic mutations lead to dyslipidaemia, and the mechanisms of action of both established and novel lipid-modifying drugs. The poster was produced with support from Regeneron Pharmaceuticals, Inc. and Sanofi.
Main pages for finding content:
Current Issue
Featured article
New devices for TAVI: technologies and initial clinical experiences
Maurizio Taramasso, Alberto Pozzoli, Azeem Latib, Giovanni La Canna, Antonio Colombo, Francesco Maisano & Ottavio Alfieri
Transcatheter aortic valve implantation (TAVI) is increasingly used to treat patients with aortic stenosis for whom the risks associated with surgery are very high. In this Review, the new generation of TAVI devices are discussed, many of which have features that allow repositioning of the device and reduce paravalvular leakage.
Current Issue
Featured article
OPINION: A TACTful reappraisal of chelation therapy in cardiovascular disease
Mandeep S. Sidhu, Basil M. Saour & William E. Boden
Chelation therapy with ethylenediamine tetra acetic acid is increasingly being used in patients with cardiovascular disease, without definitive evidence for its efficacy. In this Perspectives article, Sidhu et al. discuss data from major studies of chelation therapy in this field, with particular emphasis on TACT. They opine that the findings from this trial are not robust and do not marshal evidence in support of the potential clinical use of chelation therapy for cardiovascular disease.
OTHER INFORMATION
CONFERENCES
Click here for a calendar of forthcoming meetings and workshops from across the field of cardiology, and to find out which meetings will be attended by the editors of Nature Reviews Cardiology.
Current Issue
Also in this issue
News and Views: Acute coronary syndromes: Targeting inflammation—what has the VISTA-16 trial taught us?
Michelle L. O'Donoghue
Review: Inherited risk factors for venous thromboembolism
Ida Martinelli, Valerio De Stefano & Pier Mannuccio Mannucci
Review: Treatment of dystrophin cardiomyopathies
Josef Finsterer & Linda Cripe
Forthcoming articles
Don't miss the following articles that will soon be appearing in Nature Reviews Cardiology!
News & Views:
HYPERTENSION: Strengths and limitations of the JNC 8 hypertension guidelines
Giuseppe Mancia
Review:
The dynamics of the coronary collateral circulation
Marco Zimarino, Mariangela D'Andreamatteo, Ron Waksman, Stephen E. Epstein & Raffaele De Caterina
Review:
Potential drug targets for calcific aortic valve disease
Joshua D. Hutcheson, Elena Aikawa & W. David Merryman
Please note that the title details are not finalized and might be subject to change
2012 Journal Citation Reports (Thomson Reuters, 2013). Nature Reviews Cardiology was previously published as Nature Clinical Practice Cardiovascular Medicine.


